Clinical Trials Browser

Interventional × Uterine Cervical Neoplasms × toripalimab × Clear all

NCT04651127 2026-03-10

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Phase 1/2 Terminated

Uterine Cervical Neoplasms

NCT07363330 2026-01-26

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence

NCT06416696 2026-01-02

Toripalimab for High-risk Locally Advanced Cervical Cancer

Phase 2 Active not recruiting

Uterine Cervical Neoplasms

NCT05427396 2025-12-03

A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors

Phase 1 Terminated

GastrointestinalGynecologic

Esophageal Squamous Cell Carcinoma, Uterine Cervical Neoplasms, Liver Neoplasms

NCT07092696 2025-07-30

Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy for Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT06093438 2025-03-11

Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer

Phase 1/2 Recruiting

Uterine Cervical Neoplasms

NCT05955105 2024-05-21

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Phase 1/2 Recruiting

BreastDermatologicGynecologicHead & NeckSarcomaThoracic

Nasopharyngeal Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06256224 2024-04-24

Toripalimab Combined With Definitive CCRT for LACC Patients

Phase NA Recruiting

Uterine Cervical Neoplasms

NCT05342506 2022-04-22

Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies

Phase 2 Unknown

Uterine Cervical Neoplasms, Ovarian Neoplasms

NCT04973904 2021-07-22

Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT04395612 2021-05-21

CQGOG0101

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT04368273 2020-04-29

CCRT+PD-1

Phase 1/2 Unknown

Uterine Cervical Neoplasms